Literature DB >> 29063664

Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy.

Pat W Whitworth1, Andrea Cooper1.   

Abstract

This single-institution experience evaluated the use of bioimpedance spectroscopy to facilitate early detection and treatment of breast cancer-related lymphedema (BCRL) in a cohort of 596 patients (79.6% high risk). Seventy-three patients (12%) developed an elevated L-Dex score with axillary lymph node dissection (P < .001), taxane chemotherapy (P = .008), and regional nodal irradiation (P < .001) associated. At last follow-up, only 18 patients (3%) had unresolved clinically significant BCRL requiring complete decongestive physiotherapy. This rate of BCRL is lower than reported in contemporary studies, supporting recent NCCN guidelines promoting prospective screening, education and intervention for BCRL.
© 2017 The Authors. The Breast Journal Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  bioimpedance; breast cancer; early detection; lymphedema; surveillance

Mesh：

Year:  2017        PMID： 29063664     DOI： 10.1111/tbj.12939

Source DB:  PubMed          Journal:  Breast J        ISSN： 1075-122X            Impact factor:   2.431


  8 in total

1.  The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements.

Authors:  Pınar Borman; Ayşegül Yaman; Lütfi Doğan; Ayşe Arıkan Dönmez; Esra Gizem Koyuncu; Ayşegül Balcan; Sercan Aksoy; Cihangir Özaslan; Rabiye Akın; Kaniye Üneş
Journal:  Eur J Breast Health       Date:  2022-04-01

2.  Magnetic resonance imaging and bioimpedance evaluation of lymphatic abnormalities in patients with breast cancer treatment-related lymphedema.

Authors:  Paula M C Donahue; Rachelle Crescenzi; Chelsea Lee; Maria Garza; Niral J Patel; Kalen J Petersen; Manus J Donahue
Journal:  Breast Cancer Res Treat       Date:  2020-06-29       Impact factor: 4.872

Review 3.  Secondary lymphedema from cancer therapy.

Authors:  Michael Bernas; Saskia R J Thiadens; Paula Stewart; Jay Granzow
Journal:  Clin Exp Metastasis       Date:  2021-05-05       Impact factor: 5.150

4.  Interventions for Breast Cancer-Related Lymphedema: Clinical Practice Guideline From the Academy of Oncologic Physical Therapy of APTA.

Authors:  Claire Davies; Kimberly Levenhagen; Kathryn Ryans; Marisa Perdomo; Laura Gilchrist
Journal:  Phys Ther       Date:  2020-07-19

5.  Preventing Breast Cancer-Related Lymphedema in High-Risk Patients: The Impact of a Structured Surveillance Protocol Using Bioimpedance Spectroscopy.

Authors:  Pat W Whitworth; Chirag Shah; Frank Vicini; Andrea Cooper
Journal:  Front Oncol       Date:  2018-06-12       Impact factor: 6.244

6.  Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.

Authors:  Frank Vicini; Chirag Shah; Pat Whitworth; Michael Walker; Jing Shi
Journal:  Lymphat Res Biol       Date:  2018-08-22       Impact factor: 2.589

7.  Early surveillance is associated with less incidence and severity of breast cancer-related lymphedema compared with a traditional referral model of care.

Authors:  Louise A Koelmeyer; Robert J Borotkanics; Jessica Alcorso; Philip Prah; Caleb J Winch; Kristine Nakhel; Catherine M Dean; John Boyages
Journal:  Cancer       Date:  2018-12-06       Impact factor: 6.860

8.  The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.

Authors:  Chirag Shah; April Zambelli-Weiner; Nicole Delgado; Ashley Sier; Robert Bauserman; Jerrod Nelms
Journal:  Breast Cancer Res Treat       Date:  2020-11-27       Impact factor: 4.872
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.